S&P 500   4,278.86 (+0.12%)
DOW   33,523.29 (-0.12%)
QQQ   354.63 (-0.08%)
AAPL   179.33 (-0.14%)
MSFT   333.62 (-0.69%)
META   272.06 (+0.25%)
GOOGL   127.70 (+1.34%)
AMZN   126.50 (+0.96%)
TSLA   220.24 (+1.21%)
NVDA   385.35 (-1.62%)
NIO   7.83 (+2.09%)
BABA   86.77 (+2.81%)
AMD   122.96 (+4.27%)
T   15.62 (+1.49%)
F   12.89 (+2.38%)
MU   67.50 (-0.40%)
CGC   0.73 (-6.62%)
GE   105.28 (+1.13%)
DIS   92.17 (+1.29%)
AMC   4.65 (+0.43%)
PFE   38.43 (-0.57%)
PYPL   64.84 (+0.51%)
NFLX   398.76 (-1.18%)
S&P 500   4,278.86 (+0.12%)
DOW   33,523.29 (-0.12%)
QQQ   354.63 (-0.08%)
AAPL   179.33 (-0.14%)
MSFT   333.62 (-0.69%)
META   272.06 (+0.25%)
GOOGL   127.70 (+1.34%)
AMZN   126.50 (+0.96%)
TSLA   220.24 (+1.21%)
NVDA   385.35 (-1.62%)
NIO   7.83 (+2.09%)
BABA   86.77 (+2.81%)
AMD   122.96 (+4.27%)
T   15.62 (+1.49%)
F   12.89 (+2.38%)
MU   67.50 (-0.40%)
CGC   0.73 (-6.62%)
GE   105.28 (+1.13%)
DIS   92.17 (+1.29%)
AMC   4.65 (+0.43%)
PFE   38.43 (-0.57%)
PYPL   64.84 (+0.51%)
NFLX   398.76 (-1.18%)
S&P 500   4,278.86 (+0.12%)
DOW   33,523.29 (-0.12%)
QQQ   354.63 (-0.08%)
AAPL   179.33 (-0.14%)
MSFT   333.62 (-0.69%)
META   272.06 (+0.25%)
GOOGL   127.70 (+1.34%)
AMZN   126.50 (+0.96%)
TSLA   220.24 (+1.21%)
NVDA   385.35 (-1.62%)
NIO   7.83 (+2.09%)
BABA   86.77 (+2.81%)
AMD   122.96 (+4.27%)
T   15.62 (+1.49%)
F   12.89 (+2.38%)
MU   67.50 (-0.40%)
CGC   0.73 (-6.62%)
GE   105.28 (+1.13%)
DIS   92.17 (+1.29%)
AMC   4.65 (+0.43%)
PFE   38.43 (-0.57%)
PYPL   64.84 (+0.51%)
NFLX   398.76 (-1.18%)
S&P 500   4,278.86 (+0.12%)
DOW   33,523.29 (-0.12%)
QQQ   354.63 (-0.08%)
AAPL   179.33 (-0.14%)
MSFT   333.62 (-0.69%)
META   272.06 (+0.25%)
GOOGL   127.70 (+1.34%)
AMZN   126.50 (+0.96%)
TSLA   220.24 (+1.21%)
NVDA   385.35 (-1.62%)
NIO   7.83 (+2.09%)
BABA   86.77 (+2.81%)
AMD   122.96 (+4.27%)
T   15.62 (+1.49%)
F   12.89 (+2.38%)
MU   67.50 (-0.40%)
CGC   0.73 (-6.62%)
GE   105.28 (+1.13%)
DIS   92.17 (+1.29%)
AMC   4.65 (+0.43%)
PFE   38.43 (-0.57%)
PYPL   64.84 (+0.51%)
NFLX   398.76 (-1.18%)
NYSE:NGVT

Ingevity (NGVT) Stock Forecast, Price & News

$53.51
+1.78 (+3.44%)
(As of 02:50 PM ET)
Compare
Today's Range
$51.49
$53.93
50-Day Range
$47.19
$74.01
52-Week Range
$46.52
$90.81
Volume
206,706 shs
Average Volume
290,377 shs
Market Capitalization
$1.94 billion
P/E Ratio
10.13
Dividend Yield
N/A
Price Target
$66.33

Ingevity MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
23.2% Upside
$66.33 Price Target
Short Interest
Healthy
1.87% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of Ingevity in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$116,559 Sold Last Quarter
Proj. Earnings Growth
23.64%
From $5.50 to $6.80 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

Basic Materials Sector

18th out of 165 stocks

Chemicals & Allied Products Industry

4th out of 16 stocks


NGVT stock logo

About Ingevity (NYSE:NGVT) Stock

Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.

Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Stock News Headlines

Ingevity (NYSE:NGVT) Hits New 12-Month Low at $49.29
Soaring EV Industry Keeps Investor Focus on Lithium
The need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production.
What 7 Analyst Ratings Have To Say About Ingevity
BMO Capital Remains a Buy on Ingevity (NGVT)
Ingevity (NYSE:NGVT) PT Lowered to $55.00
The Ignored EV Story Few Investors Know About
Lithium may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain.
Ingevity (NYSE:NGVT) Downgraded to "Hold" at Loop Capital
Ingevity (NGVT) to Release Earnings on Wednesday
Ingevity (NGVT) Lags Q4 Earnings and Revenue Estimates
See More Headlines

NGVT Price History

NGVT Company Calendar

Last Earnings
5/03/2023
Today
6/06/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
2,050
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$66.33
High Stock Price Forecast
$80.00
Low Stock Price Forecast
$55.00
Forecasted Upside/Downside
+28.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$211.60 million
Pretax Margin
15.26%

Debt

Sales & Book Value

Annual Sales
$1.67 billion
Cash Flow
$9.09 per share
Book Value
$18.68 per share

Miscellaneous

Free Float
36,044,000
Market Cap
$1.88 billion
Optionable
Optionable
Beta
1.83

Key Executives

  • John C. Fortson
    President, Chief Executive Officer & Director
  • Mary Dean Hall
    Chief Financial Officer & Executive Vice President
  • Stuart Edward WoodcockStuart Edward Woodcock
    Executive VP & President-Performance Materials
  • Erik Ripple
    Senior VP, Chief Growth & Innovation Officer
  • Steven Paul Hulme
    SVP & President-Advanced Polymer Technologies













NGVT Stock - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" NGVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NGVT, but not buy additional shares or sell existing shares.
View NGVT analyst ratings
or view top-rated stocks.

What is Ingevity's stock price forecast for 2023?

3 analysts have issued 12 month target prices for Ingevity's shares. Their NGVT share price forecasts range from $55.00 to $80.00. On average, they predict the company's share price to reach $66.33 in the next year. This suggests a possible upside of 28.2% from the stock's current price.
View analysts price targets for NGVT
or view top-rated stocks among Wall Street analysts.

How have NGVT shares performed in 2023?

Ingevity's stock was trading at $70.44 at the beginning of 2023. Since then, NGVT stock has decreased by 26.6% and is now trading at $51.73.
View the best growth stocks for 2023 here
.

Are investors shorting Ingevity?

Ingevity saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 672,500 shares, a decline of 20.8% from the April 30th total of 849,600 shares. Based on an average trading volume of 330,400 shares, the days-to-cover ratio is presently 2.0 days. Approximately 1.9% of the shares of the company are short sold.
View Ingevity's Short Interest
.

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our NGVT earnings forecast
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) posted its quarterly earnings data on Wednesday, May, 3rd. The company reported $1.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.26 by $0.17. The company earned $392.60 million during the quarter, compared to the consensus estimate of $411.22 million. Ingevity had a net margin of 12.01% and a trailing twelve-month return on equity of 30.82%. Ingevity's quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the company earned $1.62 EPS.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.75 billion-$1.95 billion, compared to the consensus revenue estimate of $1.92 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Who are Ingevity's major shareholders?

Ingevity's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.05%), LSV Asset Management (4.08%), Wellington Management Group LLP (3.65%), State Street Corp (3.33%), Thrivent Financial for Lutherans (3.14%) and Victory Capital Management Inc. (2.38%). Insiders that own company stock include Erik Spencer Ripple, Phillip John Platt, Richard Allen White Jr and Stuart Edward Jr Woodcock.
View institutional ownership trends
.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $51.73.

How much money does Ingevity make?

Ingevity (NYSE:NGVT) has a market capitalization of $1.88 billion and generates $1.67 billion in revenue each year. The company earns $211.60 million in net income (profit) each year or $5.28 on an earnings per share basis.

How many employees does Ingevity have?

The company employs 2,050 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (843) 740-2300, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165.

This page (NYSE:NGVT) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -